PostpartumNCT04005391
Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women
A study testing Offer of Participant's Choice of Contraception Method in people with Postpartum, run by University of Colorado, Denver at 2 sites in 2 countries.
Trial summary
Abstract Background: Postpartum contraception is important to prevent unintended and closely spaced pregnancies following childbirth. Methods: This study is a cluster-randomized trial of communities in rural Guatemala where women receive ante- and postnatal care through a community-based nursing program. Read more about this study
- Who is it for?
- Ages 15 to 35 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Postpartum
- What is being tested?
- Offer of Participant's Choice of Contraception Method
- Type of treatment
- Pill or oral medicine, Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 208 participants
- Where
- 2 sitesin 2 countries
- Study dates
- 23 Oct 2018to 19 Nov 2020
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 35 years
- Women only
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- postpartum state
- enrolled in the Madres Sanas program
- able and willing to consent
- meeting age criteria
- not already received a contraceptive method
Who cannot join
- unable or unwilling to provide informed consent
- does not meet age criteria
- has already used a contraceptive method
- is pregnant
Trial locations and contacts
2 sites in 2 countries.
2 sites in 2 countries
Guatemala1 site
Fundacion para la Salud Integral de los Guatemaltecos
Caballo Blanco, Ritalhuleu
About this study
Official title: Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: a Cluster-randomized Trial
Abstract
Background: Postpartum contraception is important to prevent unintended and closely spaced pregnancies following childbirth.
Read more
Methods: This study is a cluster-randomized trial of communities in rural Guatemala where women receive ante- and postnatal care through a community-based nursing program. When nurses visit women for their postpartum visit in the intervention clusters, instead of providing only routine care that includes postpartum contraceptive education and counseling, the nurses will also bring a range of barrier, short-acting, and long-acting contraceptives that will be offered and administered in the home setting, after routine clinical care is provided.
Discussion: A barrier to postpartum contraception is access to medications and devices. The study removes some access barriers (distance, time, cost) by providing contraception in the home. The community nurses were trained to place implants, which are a type of long-acting reversible contraceptive method that was previously only available in the closest town, which is about an hour away by vehicle. Therefore, the study examines how home-based delivery of routinely available contraceptives and the less routinely available implant may be associated with increased uptake of postpartum contraception within three months of childbirth. The potential implications of this study include: nurses may be able to be trained to safely provide contraceptives, including place implants, in the home setting, and provision of home-based contraception may be an effective way of delivering an evidence-based intervention for preventing unintended and closely spaced pregnancies in the postpartum period.
Read the detailed description
Background and Rationale: Postpartum contraception is important to prevent unintended and closely spaced pregnancies following childbirth as well as to avoid future pregnancy in mothers who have achieved their desired family size. Proper pregnancy spacing can prevent maternal and perinatal morbidity and mortality. Globally, there is significant unmet need for postpartum contraception.
Historically, in the community of interest, which is in the rural Southwest corner of Guatemala bordering Mexico, a large majority (88%) of a convenience sample of women in the community-based care program self-reported postpartum contraceptive use. However, 72% of these women were using injectable contraceptives, which are considered short-acting, and are less effective at preventing unintended and closely spaced pregnancies; the second most common method was sterilization (21%). For the remaining women who did not seek sterilization or injectable contraceptives, 0.5% of them reportedly used contraceptive pills, 0.5% condoms, 0.5% lactational amenorrhea, and 1.6% reportedly relied on natural family planning. Less than 4% of women were using long-acting reversible contraceptives (intrauterine devices or implants), which are more effective at preventing unintended and closely spaced pregnancies than injectables. The providers in the community had not been trained in implant and intrauterine device placement, so the closest place to have a device placed was the most proximate town to the communities, which is an hour away by vehicle. Additional barriers discovered through qualitative research in the study communities found that barriers to family planning use historically included knowledge, access to methods, fear of adverse events, and a woman garnering her partner's approval. Community women's ideas for future educational programming included teaching about how birth control methods work, how to talk to partners about birth spacing, and myth debunking, and they requested the location and time of teaching to occur at peripartum and pediatric visits.
Therefore, based on this preliminary data, the prospective research question is: if community-based nurses are trained to place contraceptive implants, and they offer women placement in the home at their postpartum visit (among other routinely available contraceptive methods), will the ability to provide this service increase the uptake of contraceptive implants in our communities of interest?
Specific Objectives or Hypotheses: The specific objective of the study is to observe in this population where use of postpartum contraception is historically common among women, does home delivery of the contraceptive implant increase utilization of the device above the baseline rate of 3.2%. The investigators hypothesize, based on published data from other settings, that if women receive proper counseling about all contraceptive methods, uptake of long-acting reversible contraceptives, which in this study includes only the contraceptive implant, is about 50%.
The secondary objectives are to observe if the home-based contraceptive delivery intervention featured in this study is associated with overall increased contraceptive uptake, continuation, and satisfaction in the intervention compared to the control clusters. The hypothesis is that with increased uptake of the implant there will be longer continuation rates and more satisfaction in the intervention clusters. The investigators also hypothesize that increased contraceptive uptake, continuation, and satisfaction may be associated with reduced short interval repeat pregnancy rates so the study also aims to survey participants on their pregnancy status at enrollment, and three- and twelve-months after enrollment.
Trial Design: The protocol features an interventional, cluster-randomized, unmasked, parallel group trial design. The eight study communities were randomized in a 1:1 allocation ratio to either the intervention or control arms of the study, and the study is designed on a superiority framework.
Study Setting: The study setting is in the home of women enrolled in the "Madres Sanas" community-based nursing program offered by the Fundación para la Salud Integral de los Guatemaltecos (FSIG). FSIG supports a community-based clinic called the Center for Human Development in a region of Guatemala informally referred to as the Southwest Trifinio. This region is at the intersection of the boundaries of three departments in Guatemala, and as such no single Department takes responsibility for the health of the migrant workers that reside there. The impoverished area has a population of around 25,000 people and experiences poor pregnancy outcomes. This is why the University of Colorado Center for Global Health, in partnership with AgroAmerica, built the Center for Human Development clinic and initiated the community-based maternal and perinatal care programs, called Madres Sanas and Ninos Sanos, respectively.
Madres Sanas is executed by teams of community nurses. The nurse teams are comprised of two nurses, who are responsible for a segment of the communities in the region. There are ten communities in the Madres Sanas program that were combined into eight clusters; our biostastician did this in order to achieve similar cluster sizes, which was determined by the number of births in the communities in 2017. Because our study enrolls women at their final Madres Sanas visit, which is a postpartum visit that occurs about forty days out from delivery, the cluster size was based on delivery volume of the communities. The nurse teams are assigned by the nursing supervisor to their respective communities. They drive auto rickshaws provided by the Center for Human Development out to the communities to conduct their home visits, which include four antenatal visits and two postpartum visits. During the visits the nurses both provide clinical care and collect quality improvement and research data, and as such serve a dual function in their role. As noted, this study takes place at the final Madres Sanas visit, which occurs forty days after delivery. Routine clinical care, including postpartum contraceptive education, culminates at this time, although counseling on postpartum contraception begins at the enrollment visit. After routine clinical care is provided, the nurses offer enrollment in the study.
Interventions: All study activities and procedures begin at the forty-day postpartum visit, which is the sixth and final scheduled visit of the Madres Sanas program. At this visit the community nurses perform routine maternal and neonatal clinical care, which includes amongst other activities, final counseling and education about postpartum contraception. In intervention clusters, nurse teams bring a kit with them to the visit. After the visit they describe the study and offer consent. Once a woman has discussed the risks, benefits, and alternatives with her providers and determines she wishes to participate in the study, she signs the consent form and the nurses offer her condoms, contraceptive pills, a medroxyprogesterone contraceptive injection, or the levonorgestrel implant. The kit is stocked with 10 condoms, one pack of pills, one syringe of medroxyprogesterone, and one implant for each postpartum visit planned for that day. It also contains all the necessary materials to place the implant or administer the injection under sterile conditions, such as alcohol swabs and sterile gloves, etc.
All contraceptives are purchased using study funds and are sourced from a local provider of contraceptive medications and devices. All contraceptives are routinely available and approved for distribution in Guatemala. Because these are routinely available medications and the study does not testing their effectiveness as contraceptives, there are no criteria for discontinuing or modifying allocated interventions for a given trial participant such as changing the drug dosing. Women are, however, screened for contraindications to the contraceptive methods provided using the Medical Eligibility Criteria. The nurses have the eligibility criteria chart in Spanish, laminated, and included in their kit for use during study enrollment. As this is a pragmatic trial, there are no restrictions on care and interventions that are permitted or prohibited during the trial. For example, if a participant did not initiate a contraceptive method and wishes to, she can seek the method in the community. Conversely, if she chose a method and opted for the implant but does not like it, she is free to remove it at any time. The nurses will either remove it in the home setting or advise the woman to present to the Center for Human Development where they can remove it and potentially initiate a new method. The initial contraceptive provided in the study setting is free, but any contraceptives sought or utilized after the study enrollment visit is the woman's responsibility to locate and finance. Study contraceptives are only provided in the home setting by the nurses at the enrollment visit and are not available or offered at any subsequent visit.
Data Collection Methods: Quality improvement data from prior to study initiation was collected from June 2017 - September 2018 by the Madres Sanas community nurses. This database includes antepartum, intrapartum, and postpartum quality improvement data collected by the community nurses during routine antenatal and postnatal care visits. The data is collected on tablets and transmitted through the application REDCap. REDCap (Research Electronic Data Capture) is a secure, HIPAA-compliant web-based application designed for data collection for research studies. It provides an easy-to-use data entry system with data validation, the ability to import data from external sources (Guatemala), automated exports to statistical software, audit trails, branching logic and calculations, and sophisticated tool for building and managing online surveys. As the community nurses have been using this software for years, our study links to the Madres Sanas dataset, but involves separate forms in a separate REDCap database. Just as the nurses prompt women during routine visits and collect general pregnancy outcomes data for our quality improvement database, so will they use REDCap and the same methods to collect enrollment and follow-up on participants and transmit the data to password protected servers at the University of Colorado. There are cluster-specific REDCap forms that are collected on enrollment, at three months, and at twelve months following enrollment.
Statistical Methods: To analyze our primary outcome the investigators are planning a difference in differences analysis of the proportion of women actively using a contraceptive implant three months after enrollment in intervention clusters as compared to control clusters. The investigators plan to provide an unadjusted analysis and an adjusted analysis for any cluster characteristics that are imbalanced between the two study arms. Once the primary outcome is assessed, the investigators will likely use multivariate modeling to determine characteristics of women, in each study arm, who used any postpartum contraception within three months of delivery as compared to those who didn't, in both adjusted and unadjusted analysis. The plan is to use descriptive statistics to compare the other secondary outcomes between study arms (continuation and satisfaction). Finally, analysts will likely perform survival analysis of time to repeat pregnancy by study arm to observe if there is any statistically significant difference in the time to repeat pregnancy of women who became pregnant by twelve months in the study groups. In summary, our analysis plans a difference in differences analysis for our primary outcome, bivariate and multivariate analyses for our secondary outcome of any contraception use by study arm, descriptive statistics for our secondary outcomes of continuation and satisfaction rates among contraceptive users by study arm, and a survival analysis for time to repeat pregnancy by study arm.
- Conditions
- Postpartum
- Being tested
- Offer of Participant's Choice of Contraception Method
- Keywords
- postpartum contraception, long-acting reversible contraceptives, implant, nursing, community programming, cluster-randomized trial
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Offer of Participant's Choice of Contraception MethodOther
Also called condoms, contraceptive pills, medroxyprogesterone acetate injection, levonorgestrel implant
Women will be offered a range of contraceptive options (condoms, contraceptive pills, medroxyprogesterone acetate injection, levonorgestrel implant) to choose from; they can decline to start a contraceptive method
| Study group | Role | What they receive |
|---|---|---|
| Postpartum Contraceptives offered to Intervention Clusters | Experimental | Women will have postpartum contraceptive options (condoms "vive amor", birth control pills "segura plus", injectable "cyclofem", contraceptive implant "jadelle") offered to them at their routine forty day postpartum visit after routine care is provided, first. Receives: Other: Offer of Participant's Choice of Contraception Method |
| Routine Care offered to Control Clusters | No intervention | Women will receive routine postpartum care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Participants With Implant Use at Three Months
Measured: Three months
Secondary outcomes (4)
Number of Participants With Any Contraceptive Use at Three Months
Participants actively using any contraceptive method three months after enrollment in the study as assessed by the three-month survey
Measured: 3 Months
Contraceptive Satisfaction at Twelve Months
Participant satisfaction with any contraceptive method the woman might be using as determined by a survey question that asks if the woman is very satisfied, satisfied, dissatisfied, or very dissatisfied.
Measured: 12 Months
Number of Participants With Contraceptive Continuation at Twelve Months
Continuation of any contraceptive method a woman started in the postpartum period assessed by a survey at three and twelve months after study enrollment
Measured: 12 Months
Number of Participants With Repeat Pregnancy at Twelve Months
Repeat pregnancy after enrollment in the study, as assessed at the enrollment (baseline) visit and at three and twelve months after study enrollment.
Measured: 12 Months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jul 2019
- Study start23 Oct 2018
- Primary completion19 Feb 2020
- Study completion19 Nov 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for PostpartumStudies of the same condition, open and under way.
- More trials run by University of Colorado, DenverThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Superiority trial to see if home-based postpartum contraceptive delivery, including a long-acting reversible contraceptive, the contraceptive implant, increases uptake of a highly effective method of postpartum contraception (the implant).
- Masking
- None (open label)
- Enrolment
- 208 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Colorado, Denver
- Sponsor type
- University, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Responsible party
- Sponsor
- Investigators
- Margo S Harrison, MD, MPH, Principal investigator, University of Colorado, Denver
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04005391
- Sponsor's protocol ID
- 17-1314
- Other IDs
- 5K12HD001271
- Status last verified
- Jun 2021
- First submitted
- 26 Jun 2019
- Last updated
- 2 Jul 2021
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Harrison MS, Bunge-Montes S, Rivera C, Jimenez-Zambrano A, Heinrichs G, Bolanos A, Asturias E, Berman S, Sheeder J. Initial Contraceptive Choices of Women Enrolled in a Cluster-Randomized Trial in Southwest Trifinio, Guatemala. Matern Child Health J. 2022 Jan;26(1):168-176. doi: 10.1007/s10995-021-03275-4. Epub 2021 Oct 28.
PubMed 34709526Harrison MS, Bunge-Montes S, Rivera C, Jimenez-Zambrano A, Heinrichs G, Bolanos A, Asturias E, Berman S, Sheeder J. Primary and secondary three-month outcomes of a cluster-randomized trial of home-based postpartum contraceptive delivery in southwest Trifinio, Guatemala. Reprod Health. 2020 Aug 20;17(1):127. doi: 10.1186/s12978-020-00974-z.
PubMed 32819394Harrison MS, Bunge-Montes S, Rivera C, Jimenez-Zambrano A, Heinrichs G, Scarbro S, Juarez-Colunga E, Bolanos A, Asturias E, Berman S, Sheeder J. Delivery of home-based postpartum contraception in rural Guatemalan women: a cluster-randomized trial protocol. Trials. 2019 Nov 21;20(1):639. doi: 10.1186/s13063-019-3735-3.
PubMed 31752969
Study at a glance
From the registry record, last updated by the sponsor on 2 Jul 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women: a Cluster-randomized Trial
- ClinicalTrials.gov ID
- NCT04005391
- Acronym / sponsor ID
- 17-1314
- Conditions
- Postpartum
- Keywords
- postpartum contraception, long-acting reversible contraceptives, implant, nursing, community programming, cluster-randomized trial
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 208 participants (actual)
- Lead sponsor
- University of Colorado, DenverUniversity, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Study start
- 23 Oct 2018 (actual)
- Primary completion
- 19 Feb 2020 (actual)
- Study completion
- 19 Nov 2020 (actual)
- First posted
- 2 Jul 2019 (actual)
- Results
- Posted 24 Nov 2020
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Abstract
Background: Postpartum contraception is important to prevent unintended and closely spaced pregnancies following childbirth.
Methods: This study is a cluster-randomized trial of communities in rural Guatemala where women receive ante- and postnatal care through a community-based nursing program. When nurses visit women for their postpartum visit in the intervention clusters, instead of providing only routine care that includes postpartum contraceptive education and counseling, the nurses will also bring a range of barrier, short-acting, and long-acting contraceptives that will be offered and administered in the home setting, after routine clinical care is provided.
Discussion: A barrier to postpartum contraception is access to medications and devices. The study removes some access barriers (distance, time, cost) by providing contraception in the home. The community nurses were trained to place implants, which are a type of long-acting reversible contraceptive method that was previously only available in the closest town, which is about an hour away by vehicle. Therefore, the study examines how home-based delivery of routinely available contraceptives and the less routinely available implant may be associated with increased uptake of postpartum contraception within three months of childbirth. The potential implications of this study include: nurses may be able to be trained to safely provide contraceptives, including place implants, in the home setting, and provision of home-based contraception may be an effective way of delivering an evidence-based intervention for preventing unintended and closely spaced pregnancies in the postpartum period.
Detailed description
Background and Rationale: Postpartum contraception is important to prevent unintended and closely spaced pregnancies following childbirth as well as to avoid future pregnancy in mothers who have achieved their desired family size. Proper pregnancy spacing can prevent maternal and perinatal morbidity and mortality. Globally, there is significant unmet need for postpartum contraception.
Historically, in the community of interest, which is in the rural Southwest corner of Guatemala bordering Mexico, a large majority (88%) of a convenience sample of women in the community-based care program self-reported postpartum contraceptive use. However, 72% of these women were using injectable contraceptives, which are considered short-acting, and are less effective at preventing unintended and closely spaced pregnancies; the second most common method was sterilization (21%). For the remaining women who did not seek sterilization or injectable contraceptives, 0.5% of them reportedly used contraceptive pills, 0.5% condoms, 0.5% lactational amenorrhea, and 1.6% reportedly relied on natural family planning. Less than 4% of women were using long-acting reversible contraceptives (intrauterine devices or implants), which are more effective at preventing unintended and closely spaced pregnancies than injectables. The providers in the community had not been trained in implant and intrauterine device placement, so the closest place to have a device placed was the most proximate town to the communities, which is an hour away by vehicle. Additional barriers discovered through qualitative research in the study communities found that barriers to family planning use historically included knowledge, access to methods, fear of adverse events, and a woman garnering her partner's approval. Community women's ideas for future educational programming included teaching about how birth control methods work, how to talk to partners about birth spacing, and myth debunking, and they requested the location and time of teaching to occur at peripartum and pediatric visits.
Therefore, based on this preliminary data, the prospective research question is: if community-based nurses are trained to place contraceptive implants, and they offer women placement in the home at their postpartum visit (among other routinely available contraceptive methods), will the ability to provide this service increase the uptake of contraceptive implants in our communities of interest?
Specific Objectives or Hypotheses: The specific objective of the study is to observe in this population where use of postpartum contraception is historically common among women, does home delivery of the contraceptive implant increase utilization of the device above the baseline rate of 3.2%. The investigators hypothesize, based on published data from other settings, that if women receive proper counseling about all contraceptive methods, uptake of long-acting reversible contraceptives, which in this study includes only the contraceptive implant, is about 50%.
The secondary objectives are to observe if the home-based contraceptive delivery intervention featured in this study is associated with overall increased contraceptive uptake, continuation, and satisfaction in the intervention compared to the control clusters. The hypothesis is that with increased uptake of the implant there will be longer continuation rates and more satisfaction in the intervention clusters. The investigators also hypothesize that increased contraceptive uptake, continuation, and satisfaction may be associated with reduced short interval repeat pregnancy rates so the study also aims to survey participants on their pregnancy status at enrollment, and three- and twelve-months after enrollment.
Trial Design: The protocol features an interventional, cluster-randomized, unmasked, parallel group trial design. The eight study communities were randomized in a 1:1 allocation ratio to either the intervention or control arms of the study, and the study is designed on a superiority framework.
Study Setting: The study setting is in the home of women enrolled in the "Madres Sanas" community-based nursing program offered by the Fundación para la Salud Integral de los Guatemaltecos (FSIG). FSIG supports a community-based clinic called the Center for Human Development in a region of Guatemala informally referred to as the Southwest Trifinio. This region is at the intersection of the boundaries of three departments in Guatemala, and as such no single Department takes responsibility for the health of the migrant workers that reside there. The impoverished area has a population of around 25,000 people and experiences poor pregnancy outcomes. This is why the University of Colorado Center for Global Health, in partnership with AgroAmerica, built the Center for Human Development clinic and initiated the community-based maternal and perinatal care programs, called Madres Sanas and Ninos Sanos, respectively.
Madres Sanas is executed by teams of community nurses. The nurse teams are comprised of two nurses, who are responsible for a segment of the communities in the region. There are ten communities in the Madres Sanas program that were combined into eight clusters; our biostastician did this in order to achieve similar cluster sizes, which was determined by the number of births in the communities in 2017. Because our study enrolls women at their final Madres Sanas visit, which is a postpartum visit that occurs about forty days out from delivery, the cluster size was based on delivery volume of the communities. The nurse teams are assigned by the nursing supervisor to their respective communities. They drive auto rickshaws provided by the Center for Human Development out to the communities to conduct their home visits, which include four antenatal visits and two postpartum visits. During the visits the nurses both provide clinical care and collect quality improvement and research data, and as such serve a dual function in their role. As noted, this study takes place at the final Madres Sanas visit, which occurs forty days after delivery. Routine clinical care, including postpartum contraceptive education, culminates at this time, although counseling on postpartum contraception begins at the enrollment visit. After routine clinical care is provided, the nurses offer enrollment in the study.
Interventions: All study activities and procedures begin at the forty-day postpartum visit, which is the sixth and final scheduled visit of the Madres Sanas program. At this visit the community nurses perform routine maternal and neonatal clinical care, which includes amongst other activities, final counseling and education about postpartum contraception. In intervention clusters, nurse teams bring a kit with them to the visit. After the visit they describe the study and offer consent. Once a woman has discussed the risks, benefits, and alternatives with her providers and determines she wishes to participate in the study, she signs the consent form and the nurses offer her condoms, contraceptive pills, a medroxyprogesterone contraceptive injection, or the levonorgestrel implant. The kit is stocked with 10 condoms, one pack of pills, one syringe of medroxyprogesterone, and one implant for each postpartum visit planned for that day. It also contains all the necessary materials to place the implant or administer the injection under sterile conditions, such as alcohol swabs and sterile gloves, etc.
All contraceptives are purchased using study funds and are sourced from a local provider of contraceptive medications and devices. All contraceptives are routinely available and approved for distribution in Guatemala. Because these are routinely available medications and the study does not testing their effectiveness as contraceptives, there are no criteria for discontinuing or modifying allocated interventions for a given trial participant such as changing the drug dosing. Women are, however, screened for contraindications to the contraceptive methods provided using the Medical Eligibility Criteria. The nurses have the eligibility criteria chart in Spanish, laminated, and included in their kit for use during study enrollment. As this is a pragmatic trial, there are no restrictions on care and interventions that are permitted or prohibited during the trial. For example, if a participant did not initiate a contraceptive method and wishes to, she can seek the method in the community. Conversely, if she chose a method and opted for the implant but does not like it, she is free to remove it at any time. The nurses will either remove it in the home setting or advise the woman to present to the Center for Human Development where they can remove it and potentially initiate a new method. The initial contraceptive provided in the study setting is free, but any contraceptives sought or utilized after the study enrollment visit is the woman's responsibility to locate and finance. Study contraceptives are only provided in the home setting by the nurses at the enrollment visit and are not available or offered at any subsequent visit.
Data Collection Methods: Quality improvement data from prior to study initiation was collected from June 2017 - September 2018 by the Madres Sanas community nurses. This database includes antepartum, intrapartum, and postpartum quality improvement data collected by the community nurses during routine antenatal and postnatal care visits. The data is collected on tablets and transmitted through the application REDCap. REDCap (Research Electronic Data Capture) is a secure, HIPAA-compliant web-based application designed for data collection for research studies. It provides an easy-to-use data entry system with data validation, the ability to import data from external sources (Guatemala), automated exports to statistical software, audit trails, branching logic and calculations, and sophisticated tool for building and managing online surveys. As the community nurses have been using this software for years, our study links to the Madres Sanas dataset, but involves separate forms in a separate REDCap database. Just as the nurses prompt women during routine visits and collect general pregnancy outcomes data for our quality improvement database, so will they use REDCap and the same methods to collect enrollment and follow-up on participants and transmit the data to password protected servers at the University of Colorado. There are cluster-specific REDCap forms that are collected on enrollment, at three months, and at twelve months following enrollment.
Statistical Methods: To analyze our primary outcome the investigators are planning a difference in differences analysis of the proportion of women actively using a contraceptive implant three months after enrollment in intervention clusters as compared to control clusters. The investigators plan to provide an unadjusted analysis and an adjusted analysis for any cluster characteristics that are imbalanced between the two study arms. Once the primary outcome is assessed, the investigators will likely use multivariate modeling to determine characteristics of women, in each study arm, who used any postpartum contraception within three months of delivery as compared to those who didn't, in both adjusted and unadjusted analysis. The plan is to use descriptive statistics to compare the other secondary outcomes between study arms (continuation and satisfaction). Finally, analysts will likely perform survival analysis of time to repeat pregnancy by study arm to observe if there is any statistically significant difference in the time to repeat pregnancy of women who became pregnant by twelve months in the study groups. In summary, our analysis plans a difference in differences analysis for our primary outcome, bivariate and multivariate analyses for our secondary outcome of any contraception use by study arm, descriptive statistics for our secondary outcomes of continuation and satisfaction rates among contraceptive users by study arm, and a survival analysis for time to repeat pregnancy by study arm.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Superiority trial to see if home-based postpartum contraceptive delivery, including a long-acting reversible contraceptive, the contraceptive implant, increases uptake of a highly effective method of postpartum contraception (the implant).
| Arm | Type | Receives |
|---|---|---|
| Postpartum Contraceptives offered to Intervention Clusters | Experimental | Other: Offer of Participant's Choice of Contraception MethodWomen will have postpartum contraceptive options (condoms "vive amor", birth control pills "segura plus", injectable "cyclofem", contraceptive implant "jadelle") offered to them at their routine forty day postpartum visit after routine care is provided, first. |
| Routine Care offered to Control Clusters | No intervention | –Women will receive routine postpartum care |
Who may qualify
- Ages
- 15 to 35 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (5 listed)
- postpartum state
- enrolled in the Madres Sanas program
- able and willing to consent
- meeting age criteria
- not already received a contraceptive method
Key exclusion criteria (4 listed)
- unable or unwilling to provide informed consent
- does not meet age criteria
- has already used a contraceptive method
- is pregnant
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Offer of Participant's Choice of Contraception MethodAlso: condoms, contraceptive pills, medroxyprogesterone acetate injection, levonorgestrel implantWomen will be offered a range of contraceptive options (condoms, contraceptive pills, medroxyprogesterone acetate injection, levonorgestrel implant) to choose from; they can decline to start a contraceptive method | Other | Postpartum Contraceptives offered to Intervention Clusters |
Primary outcome
Number of Participants With Implant Use at Three Months
Time frame: Three months
4 secondary outcomes
Number of Participants With Any Contraceptive Use at Three Months
Time frame: 3 Months
Contraceptive Satisfaction at Twelve Months
Time frame: 12 Months
Number of Participants With Contraceptive Continuation at Twelve Months
Time frame: 12 Months
Number of Participants With Repeat Pregnancy at Twelve Months
Time frame: 12 Months
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Jul 2021.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 34709526Harrison MS, Bunge-Montes S, Rivera C, Jimenez-Zambrano A, Heinrichs G, Bolanos A, Asturias E, Berman S, Sheeder J. Initial Contraceptive Choices of Women Enrolled in a Cluster-Randomized Trial in Southwest Trifinio, Guatemala. Matern Child Health J. 2022 Jan;26(1):168-176. doi: 10.1007/s10995-021-03275-4. Epub 2021 Oct 28.
- Derived from this study: PubMed 32819394Harrison MS, Bunge-Montes S, Rivera C, Jimenez-Zambrano A, Heinrichs G, Bolanos A, Asturias E, Berman S, Sheeder J. Primary and secondary three-month outcomes of a cluster-randomized trial of home-based postpartum contraceptive delivery in southwest Trifinio, Guatemala. Reprod Health. 2020 Aug 20;17(1):127. doi: 10.1186/s12978-020-00974-z.
- Derived from this study: PubMed 31752969Harrison MS, Bunge-Montes S, Rivera C, Jimenez-Zambrano A, Heinrichs G, Scarbro S, Juarez-Colunga E, Bolanos A, Asturias E, Berman S, Sheeder J. Delivery of home-based postpartum contraception in rural Guatemalan women: a cluster-randomized trial protocol. Trials. 2019 Nov 21;20(1):639. doi: 10.1186/s13063-019-3735-3.
- Individual participant dataSharing planned: No
Related trials for Postpartum
Not yet recruiting
Comparison of Effect of Two Different Doses of Intravenous Oxytocin on Patients Undergoing Elective Cesarean Section
Postpartum Hemorrhage, Uterine Atony
Active, not recruitingPhase 2
Effectiveness Study of a Lifestyle Intervention Versus Metformin in Mothers With Recent Gestational Diabetes
Weight Loss, Gestational Diabetes Mellitus in Pregnancy
Recruiting
Exercise to Improve Heart and Metabolic Health After Childbirth in Women at High Risk for Preeclampsia
Postpartum Exercise, Cardiometabolic Health
RecruitingPhase 1
Ketamine Pharmacokinetics and Pharmacodynamics for Postpartum Depression and Pain After Cesarean Delivery
Pain, Postpartum Depression
Active, not recruiting
Hypopressive-Core Stabilization With and Without Whole-Body Vibration in Postpartum Pelvic Girdle Pain
Postpartum Pelvic Girdle Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Margo S Harrison, MD, MPH principal investigator
University of Colorado, Denver
2 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Offer of Participant's Choice of Contraception Method in people with Postpartum, run by University of Colorado, Denver at 2 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States, Guatemala. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 24 Nov 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of Participants With Implant Use at Three Months (time frame: Three months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04005391, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2021.